The Biogenic Eye
Download
Report
Transcript The Biogenic Eye
Mike DeSalvio, Michael Nguyen,
Khine Win, Kevin Ip, John Chi
Who
Patients suffering from non-preventable
blindness in one eye
Not designed for completely blind
Must currently retain the original eye to prevent
muscle atrophy for attachment
Screened for compatibility with blood thinners
In 2002 roughly 161 million visually impaired
world wide. (W.H.O.)
Of this 124 million had low vision
And 37 million are blind
Childhood blindness in 2002 reached 3.9%
47% caused by cataracts
Michael N
What
Bionic prosthetic camera mounted within
a silicon based plastic casing
Contains an internal reservoir with a
lacrimating compound for lubrication
Signal Processor
Radio antenna
Muscular attachments
Michael N
Where
Mounted within the eye socket of the
affected individual
Corresponding hardware is “installed”
near the occipital lobe near brain stem
Utilizing current patent WO/1999/045870
Delivery reservoir modification
Negotiate a non-exclusive licensing agreement with Johns
Hopkins University for the current technology
John
http://www.wipo.int/pctdb/en/wo.jsp?WO=1999045870
Why
Only 3.9% of children are born blind or
developed blindness. Permanent loss of
sight
Most adults loose sight because of
Cataracts (48%) and Glaucoma (12%)
Macular degeneration, corneal opacity,
and diabetes <10%
John
Why
Provide a prosthetic alternative to
clinical blindness to improve quality of
life.
Allow for more mobility
Able to drive
Depth perception
Night vision (not like night vision goggles)
Kevin
When
Total development time is 5 years
Engineering time
In vivo testing
By using an existing patent,
development time is significantly shorter
~1- 2 years
Kevin
How
The device works by transmitting a
visual image from a camera into a
processor and through the optic nerve.
Khine
Quality Function Deployment
Function
Performance
Comfort
Practicality
Style
Total
Relative Weight
(Priority)
Mike D
5
4
3
2
1
H
H
H
M
M
L
L
83
17.51%
H
H
L
M
L
H
H
M
68
69
H
H
91
30
14.35% 14.56% 19.20%
6.33%
31
102
0
0
6.54% 21.52%
0.00%
0.00%
Total
0
H
H
L
H
L
L
H
H
Pendulum Charging
prescription lens ready
Iris color options
Muscular attachment and
freedom of movement
High quality Polymer and
lactimating resevoir
Y's (What's)
Low and High lux &
resolution for better viewing
in color
Joining optic nerve and
surgical implant
X's (How's)
0
QFD Analysis
180
160
45
70
19
0
474
Analysis
Highest preference was performance
and lowest preference was style
Ability to see in darker atmospheres
significantly outweighed alternatives
Iris color was the least concerned
benefit, correlating to the customer
preference
Mike D
Expanded QFD
See Document…
Mike D
Questions